Compounded "semaglutide" is not FDA approved semaglutide.com Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT